Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by MrVerbatim9800on Dec 16, 2020 11:00am
211 Views
Post# 32118420

RE:RE:RE:Always listen to the pros

RE:RE:RE:Always listen to the pros @ Silentbull. I had a look through your past posts this morning, since you insist on having such a big mouth. You're obviously heavily vested in pot stocks, which is cool. However, you consistently contradict yourself from one week to the next, depending on how you want to spam a stock in a particular direction. You bash a stock one second and then praise it the next. EVERYONE IS AN EXPERT, UNTIL THEY'RE NOT. So, do us all a favour and sit there silently in your mothers basement, Silentbull. If you were a true professional and so confident in you predictions here, you would have just spoken your mind and moved on, but, you are shorting this stock and need it to go down. Put the lollipop back in your mouth and shut the f*ck up for a while. Move back onto the ACB or APHA boards etc etc. You know, with all do respect and such...
Silentbull wrote: under $2.60 in next 60 days...mark this prediction
cannacord genuity will make sure this goes back to pennies, thats what they do best, pump and then dump 


<< Previous
Bullboard Posts
Next >>